High levels of anti-SARS-CoV-2 IgG antibodies in previously infected patients with cancer after a single dose of BNT 162b2 vaccine
- PMID: 34217909
- PMCID: PMC8192959
- DOI: 10.1016/j.ejca.2021.05.036
High levels of anti-SARS-CoV-2 IgG antibodies in previously infected patients with cancer after a single dose of BNT 162b2 vaccine
Conflict of interest statement
Conflict of interest statement The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this article.
Figures

Comment on
-
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study.Lancet Oncol. 2021 Jun;22(6):765-778. doi: 10.1016/S1470-2045(21)00213-8. Epub 2021 Apr 27. Lancet Oncol. 2021. PMID: 33930323 Free PMC article.
-
Impaired immunogenicity of BNT162b2 anti-SARS-CoV-2 vaccine in patients treated for solid tumors.Ann Oncol. 2021 Aug;32(8):1053-1055. doi: 10.1016/j.annonc.2021.04.019. Epub 2021 Apr 28. Ann Oncol. 2021. PMID: 33932508 Free PMC article. No abstract available.
References
-
- Tougeron D., Hentzien M., Seitz-Polski B., Bani-Sadr F., Bourhis J., Ducreux M., et al. for Thésaurus National de Cancérologie Digestive (TNCD) réseau de Groupes Coopérateurs en Oncologie (GCO) Fédération Nationale des Centres de Lutte Contre le Cancer (UNICANCER) Association de Chirurgie Hépato-Bilio-Pancréatique et Transplantation (ACHBT) Association de Recherche sur les Cancers Gynécologiques-Groupes d'Investigateurs Nationaux pour l'étude des Cancers Ovariens et du Sein (ARCAGY-GINECO) Fédération Francophone de Cancérologie Digestive (FFCD) Groupe Coopérateur multidisciplinaire en Oncologie (GERCOR) Groupe d'Oncologie Radiothérapie Tête et Cou-Intergroupe ORL (GORTEC-Intergroupe ORL) Intergroupe Francophone de Cancérologie Thoracique (IFCT) InterGroupe Coopérateur de Neuro-Oncologie/Association des Neuro-Oncologues d'Expression Française (IGCNO-ANOCEF) Société Française de Chirurgie Digestive (SFCD) Société Française d'Endoscopie Digestive (SFED) Société Française de Radiothérapie Oncologique (SFRO) Société Française de Radiologie (SFR) Société Nationale Française de Colo-Proctologie (SNFCP) Société Nationale Française de Gastroentérologie (SNFGE) Severe acute respiratory syndrome coronavirus 2 vaccination for patients with solid cancer: review and point of view of a French oncology intergroup (GCO, TNCD, UNICANCER) Eur J Cancer. 2021;150:232–239. doi: 10.1016/j.ejca.2021.03.030. - DOI - PMC - PubMed
-
- Monin L., Laing A.G., Muñoz-Ruiz M., McKenzie D.R., Del Molino Del Barrio I., Alaguthurai T., et al. Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study. Lancet Oncol. 2021;S1470–2045(21):213–218. doi: 10.1016/S1470-2045(21)00213-8. - DOI - PMC - PubMed
-
- Blain H., Tuaillon E., Gamon L., Pisoni A., Miot S., Picot M.C., et al. Spike antibody levels of nursing home residents with or without prior COVID-19 3 Weeks after a single BNT162b2 vaccine dose. J Am Med Assoc. 2021 Apr 15;325(18):1898–1899. doi: 10.1001/jama.2021.6042. Online ahead of print. - DOI - PMC - PubMed
-
- Saadat S., Rikhtegaran Tehrani Z., Logue J., Newman M., Frieman M.B., Harris A.D., et al. Binding and neutralization antibody titers after a single vaccine dose in health care workers previously infected with SARS-CoV-2. J Am Med Assoc. 2021 Apr 13;325(14):1467–1469. doi: 10.1001/jama.2021.3341. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous